Latest News

CDC predicts a rise in COVID-19 hospitalizations and deaths in coming weeks


 

Coronavirus-related hospital admissions and deaths in the United States are projected to increase over the next four weeks, according to a national forecast used by the Centers for Disease Control and Prevention.

The national model also predicts that about 5,000 deaths will occur over the next two weeks, with Ohio, New Jersey, and New York projected to see the largest totals of daily deaths in upcoming weeks.

The numbers follow several weeks of steady increases in infections across the country. More than 67,000 new cases are being reported daily, according to the data tracker from The New York Times, marking a 59% increase in the past two weeks.

In the Northeast, infection rates have risen by nearly 65%. In the New York and New Jersey region, infection rates are up about 55% in the past two weeks.

Hospitalizations have already begun to climb as well, with about 19,000 COVID-19 patients hospitalized nationwide and 1,725 in intensive care, according to the latest data from the Department of Health and Human Services. In the last week, hospital admissions have jumped by 20%, and emergency department visits are up by 18%.

The CDC forecast shows that 42 states and territories will see increases in hospital admissions during the next two weeks. Florida, Minnesota, New York, and Wisconsin will see some of the largest increases.

On average, more than 2,200 COVID-19 patients are entering the hospital each day, which has increased about 20% in the last week, according to ABC News. This also marks the highest number of COVID-19 patients needing hospital care since mid-March.

Public health officials have cited several factors for the increase in cases, such as states lifting mask mandates and other safety restrictions, ABC News reported. Highly contagious Omicron subvariants, such as BA.2 and BA.2.12.1, continue to spread in the United States and escape immunity from previous infections.

The BA.2 subvariant accounts for 62% of new national cases, according to the latest CDC data. The BA.2.12.1 subvariant makes up about 36% of new cases across the United States but 62% in the New York area.

A version of this article first appeared on WebMD.com.

Recommended Reading

Peripheral muscle fatigue limits post-COVID exercise
MDedge Endocrinology
30% of COVID patients in study developed long COVID
MDedge Endocrinology
CDC panel lists reasons to get second COVID booster
MDedge Endocrinology
Myocarditis higher with Moderna COVID vax in young men
MDedge Endocrinology
COVID-19 again the third-leading cause of U.S. deaths
MDedge Endocrinology
2020 presidential election tied to spike in cardiac events
MDedge Endocrinology
One in four feel fully recovered following COVID-19 hospitalization
MDedge Endocrinology
Almost 60% of U.S. population has been infected by COVID-19: CDC
MDedge Endocrinology
When it’s not long, but medium COVID?
MDedge Endocrinology
Newly defined liver disorder associated with COVID mortality
MDedge Endocrinology